Roche’s PRX-002 shows promise in slowing Parkinson’s disease motor progression, says GlobalData
There are currently no marketed disease-modifying therapies (DMTs) for Parkinson’s disease (PD). At the American Academy of Neurology (AAN) 2024 annual meeting, Roche presented positive...